Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 55 entries
Sorted by: Best Match Show Resources per page
Effects of ion bombardment on the environmental durability of silver coatings.

Applied optics

Al-Jumaily GA.
PMID: 20555682
Appl Opt. 1989 Aug 15;28(16):3274-5. doi: 10.1364/AO.28.003274.

The effects of ion assisted deposition on the environmental durability of silver coatings have been examined. Coatings were bombarded with 300-eV argon ions during deposition. Results indicate a significant improvement in the resistance to moisture correlated with the level...

Cite
Al-Jumaily GA. Effects of ion bombardment on the environmental durability of silver coatings. Appl Opt. 1989;28(16):3274-5doi: 10.1364/AO.28.003274.
Al-Jumaily, G. A. (1989). Effects of ion bombardment on the environmental durability of silver coatings. Applied optics, 28(16), 3274-5. https://doi.org/10.1364/AO.28.003274
Al-Jumaily, G A. "Effects of ion bombardment on the environmental durability of silver coatings." Applied optics vol. 28,16 (1989): 3274-5. doi: https://doi.org/10.1364/AO.28.003274
Al-Jumaily GA. Effects of ion bombardment on the environmental durability of silver coatings. Appl Opt. 1989 Aug 15;28(16):3274-5. doi: 10.1364/AO.28.003274. PMID: 20555682.
Copy Download .nbib Format: NLM
Ion assisted deposition of optical and protective coatings for heavy metal fluoride glass.

Applied optics

McNally JJ, Al-Jumaily GA, McNeil JR, Bendow B.
PMID: 18231443
Appl Opt. 1986 Jun 15;25(12):1973. doi: 10.1364/ao.25.001973.

No abstract available.

Cite
McNally JJ, Al-Jumaily GA, McNeil JR, et al. Ion assisted deposition of optical and protective coatings for heavy metal fluoride glass. Appl Opt. 1986;25(12):1973doi: 10.1364/ao.25.001973.
McNally, J. J., Al-Jumaily, G. A., McNeil, J. R., & Bendow, B. (1986). Ion assisted deposition of optical and protective coatings for heavy metal fluoride glass. Applied optics, 25(12), 1973. https://doi.org/10.1364/ao.25.001973
McNally, J J, et al. "Ion assisted deposition of optical and protective coatings for heavy metal fluoride glass." Applied optics vol. 25,12 (1986): 1973. doi: https://doi.org/10.1364/ao.25.001973
McNally JJ, Al-Jumaily GA, McNeil JR, Bendow B. Ion assisted deposition of optical and protective coatings for heavy metal fluoride glass. Appl Opt. 1986 Jun 15;25(12):1973. doi: 10.1364/ao.25.001973. PMID: 18231443.
Copy Download .nbib Format: NLM
Computer aided diagnostic support system for skin cancer: a review of techniques and algorithms.

International journal of biomedical imaging

Masood A, Al-Jumaily AA.
PMID: 24575126
Int J Biomed Imaging. 2013;2013:323268. doi: 10.1155/2013/323268. Epub 2013 Dec 23.

Image-based computer aided diagnosis systems have significant potential for screening and early detection of malignant melanoma. We review the state of the art in these systems and examine current practices, problems, and prospects of image acquisition, pre-processing, segmentation, feature...

Cite
Masood A, Al-Jumaily AA. Computer aided diagnostic support system for skin cancer: a review of techniques and algorithms. Int J Biomed Imaging. 2013;2013:323268doi: 10.1155/2013/323268.
Masood, A., & Al-Jumaily, A. A. (2013). Computer aided diagnostic support system for skin cancer: a review of techniques and algorithms. International journal of biomedical imaging, 2013323268. https://doi.org/10.1155/2013/323268
Masood, Ammara, and Al-Jumaily, Adel Ali. "Computer aided diagnostic support system for skin cancer: a review of techniques and algorithms." International journal of biomedical imaging vol. 2013 (2013): 323268. doi: https://doi.org/10.1155/2013/323268
Masood A, Al-Jumaily AA. Computer aided diagnostic support system for skin cancer: a review of techniques and algorithms. Int J Biomed Imaging. 2013;2013:323268. doi: 10.1155/2013/323268. Epub 2013 Dec 23. PMID: 24575126; PMCID: PMC3885227.
Copy Download .nbib Format: NLM
Frequency and severity of chronic scrotal pain in Canadian men presenting to urologists for infertility investigations.

Translational andrology and urology

Aljumaily A, Forbes E, Al-Khazraji HAJ, Gordon A, Lau S, Jarvi KA.
PMID: 29354503
Transl Androl Urol. 2017 Dec;6(6):1150-1154. doi: 10.21037/tau.2017.11.28.

BACKGROUND: Chronic scrotal pain (CSP) may be debilitating in men presenting for treatment for CSP, but we have little information on the frequency and severity of CSP in the men who do not seek care for the CSP. Our...

Cite
Aljumaily A, Forbes E, Al-Khazraji HAJ, et al. Frequency and severity of chronic scrotal pain in Canadian men presenting to urologists for infertility investigations. Transl Androl Urol. 2017;6(6):1150-1154doi: 10.21037/tau.2017.11.28.
Aljumaily, A., Forbes, E., Al-Khazraji, H. A. J., Gordon, A., Lau, S., & Jarvi, K. A. (2017). Frequency and severity of chronic scrotal pain in Canadian men presenting to urologists for infertility investigations. Translational andrology and urology, 6(6), 1150-1154. https://doi.org/10.21037/tau.2017.11.28
Aljumaily, Aosama, et al. "Frequency and severity of chronic scrotal pain in Canadian men presenting to urologists for infertility investigations." Translational andrology and urology vol. 6,6 (2017): 1150-1154. doi: https://doi.org/10.21037/tau.2017.11.28
Aljumaily A, Forbes E, Al-Khazraji HAJ, Gordon A, Lau S, Jarvi KA. Frequency and severity of chronic scrotal pain in Canadian men presenting to urologists for infertility investigations. Transl Androl Urol. 2017 Dec;6(6):1150-1154. doi: 10.21037/tau.2017.11.28. PMID: 29354503; PMCID: PMC5760382.
Copy Download .nbib Format: NLM
Academic procrastination; it may be more than meets the eye.

Journal of advances in medical education & professionalism

Danesh L, Sherzai H, Mushtaq A, Al-Jumaily M, Hashemi S, Jabarkhyl D.
PMID: 33521143
J Adv Med Educ Prof. 2021 Jan;9(1):59-60. doi: 10.30476/jamp.2020.86256.1231.

No abstract available.

Cite
Danesh L, Sherzai H, Mushtaq A, et al. Academic procrastination; it may be more than meets the eye. J Adv Med Educ Prof. 2021;9(1):59-60doi: 10.30476/jamp.2020.86256.1231.
Danesh, L., Sherzai, H., Mushtaq, A., Al-Jumaily, M., Hashemi, S., & Jabarkhyl, D. (2021). Academic procrastination; it may be more than meets the eye. Journal of advances in medical education & professionalism, 9(1), 59-60. https://doi.org/10.30476/jamp.2020.86256.1231
Danesh, Laila, et al. "Academic procrastination; it may be more than meets the eye." Journal of advances in medical education & professionalism vol. 9,1 (2021): 59-60. doi: https://doi.org/10.30476/jamp.2020.86256.1231
Danesh L, Sherzai H, Mushtaq A, Al-Jumaily M, Hashemi S, Jabarkhyl D. Academic procrastination; it may be more than meets the eye. J Adv Med Educ Prof. 2021 Jan;9(1):59-60. doi: 10.30476/jamp.2020.86256.1231. PMID: 33521143; PMCID: PMC7846719.
Copy Download .nbib Format: NLM
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak Quarantine, Isolation, and Lockdown Policies on Mental Health and Suicide.

Frontiers in psychiatry

Ganesan B, Al-Jumaily A, Fong KNK, Prasad P, Meena SK, Tong RK.
PMID: 33935817
Front Psychiatry. 2021 Apr 16;12:565190. doi: 10.3389/fpsyt.2021.565190. eCollection 2021.

The novel coronavirus disease (COVID-19) pandemic has made a huge impact on people's physical and mental health, and it remains a cause of death for many all over the world. To prevent the spread of coronavirus infection, different types...

Cite
Ganesan B, Al-Jumaily A, Fong KNK, et al. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak Quarantine, Isolation, and Lockdown Policies on Mental Health and Suicide. Front Psychiatry. 2021;12:565190doi: 10.3389/fpsyt.2021.565190.
Ganesan, B., Al-Jumaily, A., Fong, K. N. K., Prasad, P., Meena, S. K., & Tong, R. K. (2021). Impact of Coronavirus Disease 2019 (COVID-19) Outbreak Quarantine, Isolation, and Lockdown Policies on Mental Health and Suicide. Frontiers in psychiatry, 12565190. https://doi.org/10.3389/fpsyt.2021.565190
Ganesan, Balasankar, et al. "Impact of Coronavirus Disease 2019 (COVID-19) Outbreak Quarantine, Isolation, and Lockdown Policies on Mental Health and Suicide." Frontiers in psychiatry vol. 12 (2021): 565190. doi: https://doi.org/10.3389/fpsyt.2021.565190
Ganesan B, Al-Jumaily A, Fong KNK, Prasad P, Meena SK, Tong RK. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak Quarantine, Isolation, and Lockdown Policies on Mental Health and Suicide. Front Psychiatry. 2021 Apr 16;12:565190. doi: 10.3389/fpsyt.2021.565190. eCollection 2021. PMID: 33935817; PMCID: PMC8085354.
Copy Download .nbib Format: NLM
Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells.

ERJ open research

Grau-Bartual S, Al-Jumaily AM, Young PM, Traini D, Ghadiri M.
PMID: 32537464
ERJ Open Res. 2020 Jun 08;6(2). doi: 10.1183/23120541.00327-2019. eCollection 2020 Apr.

Continuous positive airway pressure (CPAP) therapy is the gold standard treatment for obstructive sleep apnoea, which affects millions of people worldwide. However, this therapy normally results in symptoms such as dryness, sneezing, rhinorrhoea, post-nasal drip, nasal congestion and epistaxis...

Cite
Grau-Bartual S, Al-Jumaily AM, Young PM, et al. Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells. ERJ Open Res. 2020;6(2)doi: 10.1183/23120541.00327-2019.
Grau-Bartual, S., Al-Jumaily, A. M., Young, P. M., Traini, D., & Ghadiri, M. (2020). Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells. ERJ open research, 6(2), . https://doi.org/10.1183/23120541.00327-2019
Grau-Bartual, Sandra, et al. "Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells." ERJ open research vol. 6,2 (2020). doi: https://doi.org/10.1183/23120541.00327-2019
Grau-Bartual S, Al-Jumaily AM, Young PM, Traini D, Ghadiri M. Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells. ERJ Open Res. 2020 Jun 08;6(2). doi: 10.1183/23120541.00327-2019. eCollection 2020 Apr. PMID: 32537464; PMCID: PMC7276533.
Copy Download .nbib Format: NLM
Fabrication of Nano-Onion-Structured Graphene Films from .

ACS applied materials & interfaces

Alancherry S, Bazaka K, Levchenko I, Al-Jumaili A, Kandel B, Alex A, Robles Hernandez FC, Varghese OK, Jacob MV.
PMID: 32500707
ACS Appl Mater Interfaces. 2020 Jul 01;12(26):29594-29604. doi: 10.1021/acsami.0c04353. Epub 2020 Jun 21.

Graphene and its derivatives have acquired substantial research attention in recent years because of their wide range of potential applications. Implementing sustainable technologies for fabricating these functional nanomaterials is becoming increasingly apparent, and therefore, a wide spectrum of naturally...

Cite
Alancherry S, Bazaka K, Levchenko I, et al. Fabrication of Nano-Onion-Structured Graphene Films from . ACS Appl Mater Interfaces. 2020;12(26):29594-29604doi: 10.1021/acsami.0c04353.
Alancherry, S., Bazaka, K., Levchenko, I., Al-Jumaili, A., Kandel, B., Alex, A., Robles Hernandez, F. C., Varghese, O. K., & Jacob, M. V. (2020). Fabrication of Nano-Onion-Structured Graphene Films from . ACS applied materials & interfaces, 12(26), 29594-29604. https://doi.org/10.1021/acsami.0c04353
Alancherry, Surjith, et al. "Fabrication of Nano-Onion-Structured Graphene Films from ." ACS applied materials & interfaces vol. 12,26 (2020): 29594-29604. doi: https://doi.org/10.1021/acsami.0c04353
Alancherry S, Bazaka K, Levchenko I, Al-Jumaili A, Kandel B, Alex A, Robles Hernandez FC, Varghese OK, Jacob MV. Fabrication of Nano-Onion-Structured Graphene Films from . ACS Appl Mater Interfaces. 2020 Jul 01;12(26):29594-29604. doi: 10.1021/acsami.0c04353. Epub 2020 Jun 21. PMID: 32500707.
Copy Download .nbib Format: NLM
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).

Investigational new drugs

Hecht JR, Papadopoulos KP, Falchook GS, Patel MR, Infante JR, Aljumaily R, Wong DJ, Autio KA, Wainberg ZA, Bauer TM, Javle M, Pant S, Bendell J, Hung A, Ratti N, VanVlasselaer P, Verma R, Leveque J, Rao S, Oft M, Naing A.
PMID: 32910338
Invest New Drugs. 2021 Feb;39(1):182-192. doi: 10.1007/s10637-020-01000-6. Epub 2020 Sep 10.

Background Treatment options for pancreatic ductal adenocarcinoma (PDAC) are limited and checkpoint blockade inhibitors have been disappointing in this disease. Pegilodecakin has demonstrated single agent anti-tumor activity in immune-sensitive tumors. Phase 1 and preclinical data indicate synergy of pegilodecakin...

Cite
Hecht JR, Papadopoulos KP, Falchook GS, et al. Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Invest New Drugs. 2020;39(1):182-192doi: 10.1007/s10637-020-01000-6.
Hecht, J. R., Papadopoulos, K. P., Falchook, G. S., Patel, M. R., Infante, J. R., Aljumaily, R., Wong, D. J., Autio, K. A., Wainberg, Z. A., Bauer, T. M., Javle, M., Pant, S., Bendell, J., Hung, A., Ratti, N., VanVlasselaer, P., Verma, R., Leveque, J., Rao, S., Oft, M., & Naing, A. (2021). Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Investigational new drugs, 39(1), 182-192. https://doi.org/10.1007/s10637-020-01000-6
Hecht, J Randolph, et al. "Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)." Investigational new drugs vol. 39,1 (2021): 182-192. doi: https://doi.org/10.1007/s10637-020-01000-6
Hecht JR, Papadopoulos KP, Falchook GS, Patel MR, Infante JR, Aljumaily R, Wong DJ, Autio KA, Wainberg ZA, Bauer TM, Javle M, Pant S, Bendell J, Hung A, Ratti N, VanVlasselaer P, Verma R, Leveque J, Rao S, Oft M, Naing A. Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Invest New Drugs. 2021 Feb;39(1):182-192. doi: 10.1007/s10637-020-01000-6. Epub 2020 Sep 10. PMID: 32910338.
Copy Download .nbib Format: NLM
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research

Balmanoukian AS, Infante JR, Aljumaily R, Naing A, Chintakuntlawar AV, Rizvi NA, Ross HJ, Gordon M, Mallinder PR, Elgeioushi N, González-García I, Standifer N, Cann J, Durham N, Rahimian S, Kumar R, Denlinger CS.
PMID: 32887725
Clin Cancer Res. 2020 Dec 01;26(23):6196-6203. doi: 10.1158/1078-0432.CCR-20-0452. Epub 2020 Sep 04.

PURPOSE: The safety and preliminary efficacy of MEDI1873, an agonistic IgG1 fusion protein targeting glucocorticoid-induced TNF receptor-related protein (GITR), were evaluated in an open-label, first-in-human, phase I, dose escalation study in previously treated patients with advanced solid tumors.PATIENTS AND...

Cite
Balmanoukian AS, Infante JR, Aljumaily R, et al. Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors. Clin Cancer Res. 2020;26(23):6196-6203doi: 10.1158/1078-0432.CCR-20-0452.
Balmanoukian, A. S., Infante, J. R., Aljumaily, R., Naing, A., Chintakuntlawar, A. V., Rizvi, N. A., Ross, H. J., Gordon, M., Mallinder, P. R., Elgeioushi, N., González-García, I., Standifer, N., Cann, J., Durham, N., Rahimian, S., Kumar, R., & Denlinger, C. S. (2020). Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(23), 6196-6203. https://doi.org/10.1158/1078-0432.CCR-20-0452
Balmanoukian, Ani S, et al. "Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26,23 (2020): 6196-6203. doi: https://doi.org/10.1158/1078-0432.CCR-20-0452
Balmanoukian AS, Infante JR, Aljumaily R, Naing A, Chintakuntlawar AV, Rizvi NA, Ross HJ, Gordon M, Mallinder PR, Elgeioushi N, González-García I, Standifer N, Cann J, Durham N, Rahimian S, Kumar R, Denlinger CS. Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors. Clin Cancer Res. 2020 Dec 01;26(23):6196-6203. doi: 10.1158/1078-0432.CCR-20-0452. Epub 2020 Sep 04. PMID: 32887725.
Copy Download .nbib Format: NLM
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer.

Targeted oncology

Moore KN, Hong DS, Patel MR, Pant S, Ulahannan SV, Jones S, Meric-Bernstam F, Wang JS, Aljumaily R, Hamilton EP, Wittchen ES, Wang X, Lin AB, Bendell JC.
PMID: 34559360
Target Oncol. 2021 Sep;16(5):569-589. doi: 10.1007/s11523-021-00835-0. Epub 2021 Sep 24.

BACKGROUND: The checkpoint kinase 1 (CHK1) inhibitor prexasertib exhibited modest monotherapy antitumor activity in prior trials, suggesting that combination with chemotherapy or other targeted agents may be needed to maximize efficacy.OBJECTIVES: The aim of this study was to determine...

Cite
Moore KN, Hong DS, Patel MR, et al. A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer. Target Oncol. 2021;16(5):569-589doi: 10.1007/s11523-021-00835-0.
Moore, K. N., Hong, D. S., Patel, M. R., Pant, S., Ulahannan, S. V., Jones, S., Meric-Bernstam, F., Wang, J. S., Aljumaily, R., Hamilton, E. P., Wittchen, E. S., Wang, X., Lin, A. B., & Bendell, J. C. (2021). A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer. Targeted oncology, 16(5), 569-589. https://doi.org/10.1007/s11523-021-00835-0
Moore, Kathleen N, et al. "A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer." Targeted oncology vol. 16,5 (2021): 569-589. doi: https://doi.org/10.1007/s11523-021-00835-0
Moore KN, Hong DS, Patel MR, Pant S, Ulahannan SV, Jones S, Meric-Bernstam F, Wang JS, Aljumaily R, Hamilton EP, Wittchen ES, Wang X, Lin AB, Bendell JC. A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer. Target Oncol. 2021 Sep;16(5):569-589. doi: 10.1007/s11523-021-00835-0. Epub 2021 Sep 24. PMID: 34559360.
Copy Download .nbib Format: NLM
Ovarian germ cell tumors with rhabdomyosarcomatous components and later development of growing teratoma syndrome: a case report.

Journal of medical case reports

Al-Jumaily U, Al-Hussaini M, Ajlouni F, Abulruz A, Sultan I.
PMID: 22248255
J Med Case Rep. 2012 Jan 16;6:13. doi: 10.1186/1752-1947-6-13.

INTRODUCTION: Development of a sarcomatous component in a germ cell tumor is an uncommon phenomenon. Most cases reported have a grim prognosis. Growing teratoma syndrome is also an uncommon phenomenon and occurs in approximately 2% to 7% of non...

Cite
Al-Jumaily U, Al-Hussaini M, Ajlouni F, et al. Ovarian germ cell tumors with rhabdomyosarcomatous components and later development of growing teratoma syndrome: a case report. J Med Case Rep. 2012;6:13doi: 10.1186/1752-1947-6-13.
Al-Jumaily, U., Al-Hussaini, M., Ajlouni, F., Abulruz, A., & Sultan, I. (2012). Ovarian germ cell tumors with rhabdomyosarcomatous components and later development of growing teratoma syndrome: a case report. Journal of medical case reports, 613. https://doi.org/10.1186/1752-1947-6-13
Al-Jumaily, Usama, et al. "Ovarian germ cell tumors with rhabdomyosarcomatous components and later development of growing teratoma syndrome: a case report." Journal of medical case reports vol. 6 (2012): 13. doi: https://doi.org/10.1186/1752-1947-6-13
Al-Jumaily U, Al-Hussaini M, Ajlouni F, Abulruz A, Sultan I. Ovarian germ cell tumors with rhabdomyosarcomatous components and later development of growing teratoma syndrome: a case report. J Med Case Rep. 2012 Jan 16;6:13. doi: 10.1186/1752-1947-6-13. PMID: 22248255; PMCID: PMC3296578.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 55 entries